Industry News
Researchers Gather To Discuss Therapy Alternative For Breast Cancer
Feb 12, 2013
Radiation oncologists from some of the country's leading cancer centers will meet in Phoenix later this week to discuss the appropriate use of proton beam therapy in the treatment of breast cancer. Proton therapy is a highly precise form of radiation currently being used to treat a number of cancers and non-cancerous tumors... Read More
SUVmax Provides Valuable Indicator Of Progression-Free Survival In Stage I Non-Small Cell Lung Cancer Patients
Feb 12, 2013
SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT), according to research presented at the 2013 Cancer Imaging and Radiation Therapy Symposium... Read More
CT Texture Analysis Of Tumors May Be A Valuable Biomarker In Localized Esophageal Cancer
Feb 12, 2013
CT texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North American (RSNA)... Read More
Diffusion Abnormality Index Provides Potential Imaging Biomarker To Indicate Brain Tumor Response To Radiation Therapy
Feb 12, 2013
Diffusion abnormality index (DAI) shows promise as an imaging biomarker to measure brain tumor response to radiation therapy, according to research presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North American (RSNA)... Read More
Apogenix Receives FDA Orphan Drug Designation For Apocept(TM) To Treat Myelodysplastic Syndromes And Initiates Clinical Phase I Study
Feb 12, 2013
Apogenix GmbH, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases, announced today that its lead product, Apocept(TM) (APG101), has been granted orphan drug designation from the US Food and Drug Administration (FDA) for the treatment of Myelodysplastic syndromes (MDS)... Read More
SUVmax Provides Valuable Indicator Of Progression-Free Survival In Stage I Non-Small Cell Lung Cancer Patients
Feb 12, 2013
SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT), according to research presented at the 2013 Cancer Imaging and Radiation Therapy Symposium... Read More
In Stage I Non-Small Cell Lung Cancer Patients, SUVmax Provides Valuable Indicator Of Progression-Free Survival
Feb 12, 2013
SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT), according to research presented at the 2013 Cancer Imaging and Radiation Therapy Symposium... Read More
Diffusion Abnormality Index Provides Potential Imaging Biomarker To Indicate Brain Tumor Response To Radiation Therapy
Feb 12, 2013
Diffusion abnormality index (DAI) shows promise as an imaging biomarker to measure brain tumor response to radiation therapy, according to research presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North American (RSNA)... Read More
Hepatic Function Testing Prior To And During Radiation Therapy Can Assist In Treatment Planning For Liver Cancer Patients
Feb 12, 2013
Monitoring the hepatic function of unresectable liver cancer patients, measured by 99mTc-labeled iminodiacetic acid (HIDA) via single-photon emission computed tomography (SPECT) prior to and during radiation therapy, provides vital information that could guide more customized treatment plans and reduce risks of liver injury, according to research presented at the 2013 Cancer Im... Read More
Tumoral Texture Features May Be A Valuable Biomarker In Localized Esophageal Cancer
Feb 12, 2013
CT texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North American (RSNA)... Read More
Previous Page Next Page